REFERENCES
- Ariyoshi N., Takahashi Y., Miyamoto M., Umetsu Y., Daigo S., Tateishi T., Kobayashi S., Mizorogi Y., Loriot M. A., Stucker I., Beaune P., Kinoshita M., Kamataki T. Structural characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4C. Pharmacogenetics 2000; 10: 687–693
- Ashton H. Patterns of smoking, social and psychological factors. The Practitioner 1983; 227: 1415–1421
- Costa P. T. J., McCrae R. R. Revised NEO personality inventory (NEO-PI-R) and NEO five-factor inventory (NEO-FFI) professional manual. Psychological Assessment Resources, Odessa, FL 1992
- Dursun S. M., Kutcher S. Smoking, nicotine and psychiatric role, controversies and implications for future research. Med Hypoth. 1999; 52: 101–109
- Eysenck H. J., Eaves L. J., Kasriel J. The Causes and Effects of Smoking. Gower Publishing Company Ltd, Aldershot 1980
- Gambier N., Batt A. M., Marie B., Pfister M., Siest G., Visvikis-Siest S. Association of CYP2A6*1B genetic variant with the amount of smoking in French adults from the Stanislas cohort. Pharmacogenomics 2005; 5: 271–275
- Kwon J. T., Nakajima M., Chai S., Yom Y. K., Kim H. K., Yamazaki H., Sohn D. R., Yamamoto T., Kuroiwa Y., Yokoi T. Nicotine metabolism and CYP2A6 allele frequencies in Koreans. Pharmacogenetics. 2001; 11: 317–323
- Miyasato K. Recent advances in research on nicotine dependence and reward mechanism. Folica Pharmacol. Jpn. 2001; 117: 27–34
- Nakajima M., Kwon J. T., Tanaka N., Zenta T., Yamamoto Y., Yamamoto H., Yamazaki H., Yamamoto T., Kuroiwa Y., Yokoi T. Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans. Clin. Pharmacol. Ther. 2001; 69: 72–78
- Paterson D., Nordberg A. Neuronal nicotinic receptors in human brain. Prog. Neurobiol. 2000; 61: 75–111
- Seto M., Uesato I. The relationship among personality, behavior pattern, and smoking behavior. Brain Science Jpn. 2002; 22: 969–974
- Waga C., Iwahashi K. The relationship between smoking behavior and deletion of CYP2A6 gene in Japanese. Jpn. J. Clin. Psychiatry 2003; 32: 1557–1562
- Waga C., Terayama H., Ito M., Murayama O., Ikeda K., Iwahashi K. Association CYP2D6 gene polymorphism and anxiety of STAI with smoking behavior. Jpn. J. Clin. Psychiatry 2006; 35: 343–347
- Wei H., XieDa W., Ohara K., Miyasato K. Management for tobacco dependence. Jpn. J. Clin. Psychiatry 1991; 20: 737–744
- Yamanaka H., Nakajima M., Nishimura K., Yoshida R., Fukami T., Katoh M., Yokoi T. Metabolic profile of nicotine in subjects whose CYP2A6 gene is deleted. Eur. J. Pharm. Sci. 2004; 22: 419–425
- Yoshida R., Nakajima M., Watanabe Y., Kwon J. T., Yokoi T. Genetic polymorphisms in human CYP2A6 gene causing impaired nicotine metabolism. Br. J. Clin. Pharmacol. 2002; 54: 511–517